DK3143998T3 - Inhalerbart lægemiddel omfattende tiotropium - Google Patents
Inhalerbart lægemiddel omfattende tiotropium Download PDFInfo
- Publication number
- DK3143998T3 DK3143998T3 DK16185402.1T DK16185402T DK3143998T3 DK 3143998 T3 DK3143998 T3 DK 3143998T3 DK 16185402 T DK16185402 T DK 16185402T DK 3143998 T3 DK3143998 T3 DK 3143998T3
- Authority
- DK
- Denmark
- Prior art keywords
- product including
- medicinal product
- inhaled medicinal
- tiotropium
- including tiotropium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161577315P | 2011-12-19 | 2011-12-19 | |
GBGB1200525.2A GB201200525D0 (en) | 2011-12-19 | 2012-01-13 | An inhalable medicament |
EP12806382.3A EP2793886B1 (en) | 2011-12-19 | 2012-12-06 | An inhalable medicament comprising tiotropium |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3143998T3 true DK3143998T3 (da) | 2019-06-17 |
Family
ID=45813952
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK16185402.1T DK3143998T3 (da) | 2011-12-19 | 2012-12-06 | Inhalerbart lægemiddel omfattende tiotropium |
DK12806382.3T DK2793886T3 (da) | 2011-12-19 | 2012-12-06 | Inhalerbart medikament omfattende tiotropium |
DK12196725.1T DK2606891T3 (da) | 2011-12-19 | 2012-12-12 | Inhalerbart lægemiddel omfattende tiotropium |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK12806382.3T DK2793886T3 (da) | 2011-12-19 | 2012-12-06 | Inhalerbart medikament omfattende tiotropium |
DK12196725.1T DK2606891T3 (da) | 2011-12-19 | 2012-12-12 | Inhalerbart lægemiddel omfattende tiotropium |
Country Status (29)
Country | Link |
---|---|
US (1) | US9655969B2 (da) |
EP (3) | EP2793886B1 (da) |
JP (1) | JP5791166B2 (da) |
KR (2) | KR20160111539A (da) |
CN (1) | CN103998039A (da) |
AR (1) | AR089302A1 (da) |
AU (1) | AU2012358475B2 (da) |
BR (1) | BR112014014535A2 (da) |
CA (1) | CA2856047C (da) |
CY (1) | CY1116142T1 (da) |
DK (3) | DK3143998T3 (da) |
EA (1) | EA028461B1 (da) |
ES (3) | ES2728940T3 (da) |
GB (1) | GB201200525D0 (da) |
HK (2) | HK1198512A1 (da) |
HR (1) | HRP20141176T1 (da) |
HU (2) | HUE044647T2 (da) |
IL (1) | IL232946A0 (da) |
MX (1) | MX361925B (da) |
PL (3) | PL2793886T3 (da) |
PT (1) | PT2606891E (da) |
RS (1) | RS53783B1 (da) |
SI (1) | SI2606891T1 (da) |
SM (1) | SMT201400192B (da) |
TR (1) | TR201908429T4 (da) |
TW (1) | TWI468187B (da) |
UY (1) | UY34525A (da) |
WO (1) | WO2013092237A1 (da) |
ZA (2) | ZA201403041B (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5800829B2 (ja) | 2009-12-23 | 2015-10-28 | シエシー ファルマセウティチィ ソシエタ ペル アチオニ | Copd用エアロゾル製剤 |
GB201200525D0 (en) | 2011-12-19 | 2012-02-29 | Teva Branded Pharmaceutical Prod R & D Inc | An inhalable medicament |
JP6335798B2 (ja) | 2012-02-28 | 2018-05-30 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規噴射剤含有チオトロピウム製剤 |
MX2016006377A (es) * | 2013-11-22 | 2016-10-28 | Teva Branded Pharmaceutical Products R&D Inc | Un medicamento inhalable. |
AU2014352793B2 (en) * | 2013-11-22 | 2019-05-09 | Teva Branded Pharmaceutical Products R&D, Inc. | An inhalable medicament |
US10034866B2 (en) | 2014-06-19 | 2018-07-31 | Teva Branded Pharmaceutical Products R&D, Inc. | Inhalable medicament comprising tiotropium |
WO2017075018A1 (en) * | 2015-10-29 | 2017-05-04 | 3M Innovative Properties Company | Formulation and aerosol canisters, inhalers, and the like containing the formulation |
MX2019003097A (es) * | 2016-09-19 | 2019-09-13 | Mexichem Fluor Sa De Cv | Composicion farmaceutica. |
EP3813797A4 (en) * | 2018-06-27 | 2022-03-30 | Kindeva Drug Delivery L.P. | TIOTROPIUM FORMULATION AND INHALER |
Family Cites Families (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8828477D0 (en) | 1988-12-06 | 1989-01-05 | Riker Laboratories Inc | Medical aerosol formulations |
US5610163A (en) | 1989-09-16 | 1997-03-11 | Boehringer Ingelheim Gmbh | Esters of thienyl carboxylic acids and amino alcohols and their quaternization products |
DE3931041C2 (de) | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
GB9026191D0 (en) * | 1990-12-01 | 1991-01-16 | Harris Pharma Ltd | Breath actuated dispensing device |
IL104068A (en) | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant |
WO1993011745A1 (en) | 1991-12-12 | 1993-06-24 | Glaxo Group Limited | Medicaments |
GB2264238A (en) | 1992-05-29 | 1993-08-25 | Norton Healthcare Ltd | Medicament inhalor device |
EP0673240B1 (en) * | 1992-12-09 | 1999-03-24 | Boehringer Ingelheim Pharmaceuticals Inc. | Stabilized medicinal aerosol solution formulations |
US6258341B1 (en) | 1995-04-14 | 2001-07-10 | Inhale Therapeutic Systems, Inc. | Stable glassy state powder formulations |
US6309671B1 (en) | 1995-04-14 | 2001-10-30 | Inhale Therapeutic Systems | Stable glassy state powder formulations |
GB9616237D0 (en) | 1996-08-01 | 1996-09-11 | Norton Healthcare Ltd | Aerosol formulations |
RU2221552C2 (ru) | 1998-11-13 | 2004-01-20 | Джаго Рисерч Аг | Сухой порошок для ингаляции |
DZ2947A1 (fr) | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
CA2387212A1 (en) | 1999-10-12 | 2001-04-19 | Kaken Pharmaceutical Co., Ltd. | Dry powder inhalation and a method for the preparation thereof |
US20060257324A1 (en) * | 2000-05-22 | 2006-11-16 | Chiesi Farmaceutici S.P.A. | Pharmaceutical solution formulations for pressurised metered dose inhalers |
UA73986C2 (uk) | 2000-05-22 | 2005-10-17 | К'Єзі Фармачеутічі С.П.А. | АЕРОЗОЛЬНА КОМПОЗИЦІЯ, ЩО МІСТИТЬ <font face="Symbol">b</font>2-АДРЕНЕРГІЧНИЙ АГОНІСТ ТРИВАЛОЇ ДІЇ, ДОЗУЮЧИЙ ІНГАЛЯТОР ПІД ТИСКОМ ТА СПОСІБ ЙОГО ЗАПОВНЕННЯ |
US6553988B1 (en) | 2000-06-09 | 2003-04-29 | Norton Healthcare, Inc. | Medicament dispensing device with a multimaterial diaphragm bounding a pneumatic force chamber |
TR200402367T4 (tr) | 2000-10-12 | 2004-12-21 | Boehringer Ingelheim Pharma Gmbh& Co.Kg | Yeni tiotropyum içeren inhalasyon tozları |
DZ3478A1 (fr) | 2000-10-12 | 2002-04-18 | Boehringer Ingelheim Pharma | Monohydrate cristallin, procede pour sa fabrication et son utilisation pour la fabrication d'un medicament. |
US6908928B2 (en) | 2000-10-12 | 2005-06-21 | Bi Pharma Kg. | Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions |
PT1243263E (pt) * | 2001-03-21 | 2003-03-31 | Sanol Arznei Schwarz Gmbh | Nova utilizacao de uma classe peptidica de composto para o tratamento de alodinia ou de outros tipos diferentes de dor cronica ou fantasma |
DE10126924A1 (de) | 2001-06-01 | 2002-12-05 | Boehringer Ingelheim Pharma | Inhalationskapseln |
US20030070679A1 (en) | 2001-06-01 | 2003-04-17 | Boehringer Ingelheim Pharma Kg | Capsules containing inhalable tiotropium |
MXPA03011718A (es) | 2001-06-22 | 2004-12-06 | Boehringer Ingelheim Pharma | Agente anticolinergico cristalino, procedimiento para su preparacion y su utilizacion para preparacion de medicamento. |
US6608055B2 (en) | 2001-06-22 | 2003-08-19 | Boehringer Ingelheim Pharma Kg | Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition |
DE10130371A1 (de) * | 2001-06-23 | 2003-01-02 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika |
US20040126325A1 (en) * | 2002-03-12 | 2004-07-01 | David Lewis | Medicinal aerosol solution formulation products with improved chemical stability |
US7309707B2 (en) | 2002-03-20 | 2007-12-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament |
DE10212264A1 (de) | 2002-03-20 | 2003-10-02 | Boehringer Ingelheim Pharma | Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels |
DE10214263A1 (de) | 2002-03-28 | 2003-10-16 | Boehringer Ingelheim Pharma | HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum |
US7311894B2 (en) | 2002-03-28 | 2007-12-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | HFA suspension formulations containing an anticholinergic |
GB0219511D0 (en) | 2002-08-21 | 2002-10-02 | Norton Healthcare Ltd | Method of preparing dry powder inhalation compositions |
US20050058606A1 (en) | 2002-12-16 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Tiotropium containing HFC solution formulations |
CA2510043A1 (en) * | 2002-12-16 | 2004-07-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Tiotropium containing hfc solution formulations |
DE10339197A1 (de) | 2003-08-22 | 2005-03-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Sprühgetrocknete amorphe Pulver mit geringer Restfeuchte und guter Lagerstabilität |
EP1699435A4 (en) | 2003-09-18 | 2009-05-20 | Norton Healthcare Ltd | PARTICLE |
RS20060291A (en) | 2003-11-03 | 2008-06-05 | Boehringer Ingelheim International Gmbh., | Novel crystalline anhydride with anticholinergic effect |
US7968717B2 (en) | 2003-11-03 | 2011-06-28 | Boehringer Ingelhein International Gmbh | Crystalline anhydrate with anticholinergic efficacy |
SE0303570L (sv) | 2003-12-03 | 2005-06-04 | Microdrug Ag | Fukt-känslig medicinsk produkt |
JP2007528409A (ja) | 2004-03-09 | 2007-10-11 | アリバ ファーマシューティカルズ, インコーポレイテッド | プロテアーゼインヒビターの低用量吸入による慢性閉塞性肺疾患の処置 |
US20060079544A1 (en) | 2004-08-13 | 2006-04-13 | Boehringer Ingelheim International Gmbh | Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic |
EP1850831B1 (en) * | 2005-02-25 | 2015-12-02 | CHIESI FARMACEUTICI S.p.A. | Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent |
AU2006243238B2 (en) | 2005-05-02 | 2012-05-24 | Boehringer Ingelheim International Gmbh | Novel crystalline forms of tiotropium bromide |
CN101203513A (zh) | 2005-05-02 | 2008-06-18 | 贝林格尔·英格海姆国际有限公司 | 噻托溴铵的晶型 |
CA2611902C (en) | 2005-06-15 | 2013-08-27 | Boehringer Ingelheim International Gmbh | Tiotropium salts, compositions thereof, and processes for preparing same via tiotropium bicarbonate reacted with an acid |
BRPI0614394A2 (pt) | 2005-08-06 | 2011-03-29 | Boehringer Ingelheim Int | uso de sais de tiotrópio |
US20070088030A1 (en) | 2005-10-10 | 2007-04-19 | Barbara Niklaus-Humke | Aerosol formulations for the inhalation of beta-agonists |
CA2627729A1 (en) | 2005-12-19 | 2007-07-05 | Sicor Inc. | Novel forms of tiotropium bromide and processes for preparation thereof |
EP1923393A1 (en) | 2006-11-17 | 2008-05-21 | Boehringer Ingelheim Pharma GmbH & Co. KG | Crystalline form of tiotropium bromide and urea |
GB0716026D0 (en) | 2007-08-16 | 2007-09-26 | Norton Healthcare Ltd | An inhalable medicament |
EP2201934A1 (en) | 2008-12-23 | 2010-06-30 | CHIESI FARMACEUTICI S.p.A. | Tiotropium aerosol formulation products with improved chemical stability |
EP2389162A1 (en) | 2009-01-26 | 2011-11-30 | Teva Pharmaceutical Industries Ltd | Processes for coating a carrier with microparticles |
CN102905694B (zh) * | 2009-11-17 | 2015-10-14 | 西普拉有限公司 | 吸入溶液 |
US20120085345A1 (en) | 2010-10-12 | 2012-04-12 | Teva Branded Pharmaceutical Products R&D, Inc. | Nasal spray device |
GB201200504D0 (en) | 2011-12-19 | 2012-02-22 | Teva Branded Pharmaceutical Prod R & D Inc | An inhaler |
GB201200525D0 (en) | 2011-12-19 | 2012-02-29 | Teva Branded Pharmaceutical Prod R & D Inc | An inhalable medicament |
JP6335798B2 (ja) | 2012-02-28 | 2018-05-30 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規噴射剤含有チオトロピウム製剤 |
-
2012
- 2012-01-13 GB GBGB1200525.2A patent/GB201200525D0/en not_active Ceased
- 2012-12-06 KR KR1020167025194A patent/KR20160111539A/ko not_active Application Discontinuation
- 2012-12-06 MX MX2014007357A patent/MX361925B/es active IP Right Grant
- 2012-12-06 EP EP12806382.3A patent/EP2793886B1/en not_active Revoked
- 2012-12-06 CN CN201280060763.4A patent/CN103998039A/zh active Pending
- 2012-12-06 BR BR112014014535A patent/BR112014014535A2/pt not_active Application Discontinuation
- 2012-12-06 WO PCT/EP2012/074690 patent/WO2013092237A1/en active Application Filing
- 2012-12-06 US US14/367,031 patent/US9655969B2/en active Active
- 2012-12-06 PL PL12806382T patent/PL2793886T3/pl unknown
- 2012-12-06 PL PL16185402T patent/PL3143998T3/pl unknown
- 2012-12-06 EP EP16185402.1A patent/EP3143998B1/en active Active
- 2012-12-06 HU HUE16185402 patent/HUE044647T2/hu unknown
- 2012-12-06 DK DK16185402.1T patent/DK3143998T3/da active
- 2012-12-06 CA CA2856047A patent/CA2856047C/en not_active Expired - Fee Related
- 2012-12-06 DK DK12806382.3T patent/DK2793886T3/da active
- 2012-12-06 EA EA201491206A patent/EA028461B1/ru not_active IP Right Cessation
- 2012-12-06 ES ES16185402T patent/ES2728940T3/es active Active
- 2012-12-06 JP JP2014543943A patent/JP5791166B2/ja not_active Expired - Fee Related
- 2012-12-06 HU HUE12806382A patent/HUE030983T2/en unknown
- 2012-12-06 AU AU2012358475A patent/AU2012358475B2/en not_active Ceased
- 2012-12-06 TR TR2019/08429T patent/TR201908429T4/tr unknown
- 2012-12-06 KR KR1020147017716A patent/KR101670564B1/ko active IP Right Grant
- 2012-12-06 ES ES12806382.3T patent/ES2602314T3/es active Active
- 2012-12-12 SI SI201230113T patent/SI2606891T1/sl unknown
- 2012-12-12 PL PL12196725T patent/PL2606891T3/pl unknown
- 2012-12-12 PT PT121967251T patent/PT2606891E/pt unknown
- 2012-12-12 RS RS20140691A patent/RS53783B1/en unknown
- 2012-12-12 EP EP12196725.1A patent/EP2606891B1/en not_active Revoked
- 2012-12-12 DK DK12196725.1T patent/DK2606891T3/da active
- 2012-12-12 ES ES12196725.1T patent/ES2526685T3/es active Active
- 2012-12-18 AR ARP120104795A patent/AR089302A1/es not_active Application Discontinuation
- 2012-12-18 UY UY0001034525A patent/UY34525A/es not_active Application Discontinuation
- 2012-12-19 TW TW101148516A patent/TWI468187B/zh not_active IP Right Cessation
-
2014
- 2014-04-25 ZA ZA2014/03041A patent/ZA201403041B/en unknown
- 2014-06-02 IL IL232946A patent/IL232946A0/en active IP Right Grant
- 2014-11-27 HK HK14111996.5A patent/HK1198512A1/xx unknown
- 2014-12-04 HR HRP20141176AT patent/HRP20141176T1/hr unknown
- 2014-12-19 CY CY20141101072T patent/CY1116142T1/el unknown
- 2014-12-22 SM SM201400192T patent/SMT201400192B/xx unknown
-
2015
- 2015-01-27 HK HK15100893.1A patent/HK1200343A1/xx unknown
- 2015-03-23 ZA ZA2015/01986A patent/ZA201501986B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201703992B (en) | Inhalable pharmaceutical compositions | |
CO6852076A2 (es) | Composiciones farmacéuticas inhalables | |
DK3108966T3 (da) | Inhalator | |
DK2708255T3 (da) | Inhalator | |
DK2768559T3 (da) | Lægemiddelindgivelsesanordning | |
DK2706982T4 (da) | Intranasale farmaceutiske dosisformer omfattende naloxon | |
IL239055A0 (en) | Medical inhalation device | |
BR112014029111A2 (pt) | inalador | |
DK3143998T3 (da) | Inhalerbart lægemiddel omfattende tiotropium | |
SG11201400580VA (en) | Pharmaceutical composition for inhalation | |
DK2740504T3 (da) | Lægemiddelfremføringsanordning | |
DK2652652T3 (da) | Medikmentadministration | |
DK2800567T3 (da) | En inhalator omfattende en tiotropium-indeholdende-sammensætning | |
CO6940426A2 (es) | Formulaciones farmacéuticas | |
HK1206292A1 (en) | Medicament administration | |
BR112014015885A2 (pt) | preparação farmacêutica | |
AP2015008208A0 (en) | Pharmaceutical administration forms comprising | |
EP2898912A4 (en) | INSTRUMENT FOR MEDICINE ADMINISTRATION | |
DK2897588T3 (da) | Inhalerbart lægemiddel | |
BR112013033052A2 (pt) | formulações de entrega de fármaco | |
HK1200390A1 (en) | Inhalable microemulsion comprising anaesthetic | |
TH148769B (th) | องค์ประกอบทางเภสัชกรรมสำหรับการสูดดม | |
DK2670458T3 (da) | Lægemiddelindgivelsesanordning | |
TH148781B (th) | สารละลายสำหรับการให้ทางช่องปาก | |
GB201122337D0 (en) | Medicinal dummy |